FDA Inspection
American Red Cross Biomedical ServicesAmerican Red Cross Biomedical Services – FDA Inspection, Jun 14, 2013
Record Details
This FDA Inspection record concerns American Red Cross Biomedical Services, with an inspection on June 14, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- June 14, 2013
- Product Type
- Biologics
View Company Profile
ID · 6ccdaf78-268c-4b2a-b82a-08c9bc9d6342
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 839522
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.40(a)(1)Provide space for examination
Full citation text and observation details available on the Dashboard.
Other FDA inspections of American Red Cross Biomedical Services
3| Date | Classification | Office | Project area |
|---|---|---|---|
| July 16, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 18, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 22, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for American Red Cross Biomedical Services
- FDA Inspection 1062454 - 2018-07-16
- FDA Inspection 950529 - 2015-11-18
- FDA Inspection 732714 - 2011-06-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.